Regeneron Pharmaceuticals Inc
NASDAQ:REGN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc
Long-Term Debt
Regeneron Pharmaceuticals Inc
Long-Term Debt Peer Comparison
ABBV
GILD
AMGN
MRNA
VRTX
Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Long-Term Debt
$2.7B
|
CAGR 3-Years
11%
|
CAGR 5-Years
31%
|
CAGR 10-Years
18%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Long-Term Debt
$63.8B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
13%
|
CAGR 10-Years
16%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Long-Term Debt
$21.5B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
10%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Long-Term Debt
$60.1B
|
CAGR 3-Years
24%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
|
|
Moderna Inc
NASDAQ:MRNA
|
Long-Term Debt
$575m
|
CAGR 3-Years
61%
|
CAGR 5-Years
77%
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Long-Term Debt
$361.5m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-4%
|
See Also
What is Regeneron Pharmaceuticals Inc's Long-Term Debt?
Long-Term Debt
2.7B
USD
Based on the financial report for Mar 31, 2024, Regeneron Pharmaceuticals Inc's Long-Term Debt amounts to 2.7B USD.
What is Regeneron Pharmaceuticals Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
18%
Over the last year, the Long-Term Debt growth was 0%. The average annual Long-Term Debt growth rates for Regeneron Pharmaceuticals Inc have been 11% over the past three years , 31% over the past five years , and 18% over the past ten years .
You don't have any saved screeners yet
